PRNewswire - November 19, 2003

InfoWorld is an International Data Group (IDG) publication that delivers in-depth coverage and evaluation of IT products to over 500,000 weekly readers.

Boehringer Ingleheim -- InfoWorld 100 Winner in Healthcare Category In InfoWorld's competitive Healthcare Category, Boehringer Ingelheim Pharmaceuticals, Inc., (http://www.boehringer-ingelheim.com/ ), one of the world's 20 leading pharmaceutical companies, was acknowledged for its knowledge sharing and collaboration. Boehringer Ingelheim Pharmaceuticals, Inc. leverages the Documentum eRoom enterprise collaboration solution to bring together scientists, partners, administrators and managers, resulting in productive exchanges of information and ideas, enabling both Boehringer Ingelheim Pharmaceuticals and its partners to focus more time on the value-added aspects of their joint research and development work.

"Simply stated," said Dr. Peter Farina, vice president, Development, Boehringer Ingelheim Pharmaceuticals, Inc., "The Documentum eRoom solution enables us to match research excellence with state-of-the art business collaboration tools, to fully embrace our partners in the pursuit of better, more effective and innovative pharmaceutical products and services."

The Well Project -- InfoWorld 100 Winner in Services Category In the Services Category, The Well Project, (http://www.thewellproject.com/ ), a community-focused organization committed to improving the lives of women living with HIV and AIDS, was singled out for its innovative implementation of an enterprise content management (ECM) system. Using Documentum 5, the latest version of the Documentum ECM platform, The Well Project creates, manages, delivers and archives web content and other content assets. The Well Project selected the Documentum platform to support an abundance of content, sophisticated message boards and personalization functionality. Documentum Alliance Partner, Armedia (http://www.armedia.com), assisted The Well Project in deploying the solution.

"A primary goal for The Well Project is to provide fresh, relevant content to our site users," said Richard Averitt, chief operating officer for The Well Project. "The Documentum ECM platform accelerates web publishing process and allows non-technical users to easily contribute content for the site. We have aggressive plans for our online community, and Documentum provides a true platform to grow as our needs evolve. Documentum is also highly regarded in the pharmaceutical industry and we are confident in teaming with the market leader."

"The InfoWorld 100 recognizes companies like Boehringer Ingleheim Pharmaceuticals, Inc. and The Well Project that made the best use of technology to enhance their businesses," stated Steve Fox, editor-in-chief of InfoWorld. "Both companies built an innovative system to meet critical technical and business objectives."

About Documentum

Documentum provides enterprise content management (ECM) solutions that enable organizations to unite teams, content and associated business processes. Documentum's integrated set of content, compliance and collaboration solutions support the way people work, from initial discussion and planning through design, production, marketing, sales, service and corporate administration. With a single platform, Documentum enables people to collaboratively create, manage, deliver and archive the content that drives business operations, from documents and discussions to email, Web pages, records and rich media. The Documentum platform makes it possible for companies to distribute all of this content in multiple languages, across internal and external systems, applications and user communities. As a result, Documentum's customers, which include thousands of the world's most successful organizations, harness corporate knowledge, accelerate time to market, increase customer satisfaction, enhance supply chain efficiencies and reduce operating costs, improving their overall competitive advantage. For more information, visit Documentum on the Web at http://www.documentum.com.

NOTE: Documentum and the Documentum logo are trademarks or registered trademarks of Documentum, Inc. in the US and throughout the world. All other company and product names are used for identification purposes only and may be trademarks of their respective owners. Documentum cannot guarantee completion of any future products or product features mentioned in this document, and no reliance should be placed on their availability. Printed in the U.S.A.

In addition to historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements include, but are not limited to, statements relating to the company's momentum and continued expansion of its product offerings, diversification of its sales model, expanded global presence, increased market share, expanded revenue stream, increased cross-sell opportunities and strong execution. The company's future actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the risks associated with the software market, risks associated with development and release of new versions and new products, fluctuations in customer demand for our products, risks associated with rapid technological change, concentration of a large percentage of our quarterly revenue with a few customers, the financial, economic, political and other uncertainties caused or exacerbated by the current hostilities involving the United States and Iraq, the risk that the company will not be able to integrate its products, operations and business with acquired entities effectively, that the companies' customers, suppliers and employees will not support its acquisitions, and the other general risks of acquisitions. Such factors also include those discussed from time to time in the company's public reports filed with the Securities and Exchange Commission, such as those under "Risk Factors" included in the company's annual report on Form 10-K for the fiscal year ended December 31, 2002, as well as the company's other filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. The company undertakes no obligation to update or revise these forward-looking statements.

Unless expressly stated otherwise, the customer transaction discussed in this press release was not completed in the current quarter and any license revenue associated with such transaction should be assumed to have already been included in prior earnings announcements.

SOURCE Documentum, Inc.

Web Site: http://www.documentum.com

031119
PR031136

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .